News

Vision Restoration Using Optogenetics

Mission of Mercy brings free healthcare clinic to David L. Lawrence Convention Center

Novel gene therapy platform speeds search for ways to cure blindness

Following Luxturna and slate of eye disease approvals, Roche adds another ophthalmology partner for AAV gene therapies

Avista Therapeutics Partners with Roche to Develop Next-Generation AAV Gene Therapy Vectors for Ocular Diseases

Roche tasks Avista with scAAVenging for better eye disease gene therapy vectors

Addressing Social Determinants of Vision Health

UPMC Community Matters: Dr. Ellen Butts talks about prioritizing eye exams

Correcting night blindness in dogs

Falling Walls Breakthrough Conversation with José-Alain Sahel

Vision Restoration for Retinal Degeneration: A Neuroprotective Strategy

Winners of the Chica and Heinz Schaller Foundation Award Lecture at the FENS Forum 2022

Jose-Alain Sahel, MD, Wins Science Breakthrough of the Year in Life Sciences Award from Falling Walls Foundation in Berlin

Gene-independent therapeutic strategies for retinal degeneration include optogenetic therapy

For the First Time, Optogenetic Therapy Partially Restores Patient’s Vision